PVTTF Stock UPDATES Pivotal Therapeutics (PVTTF) 0.1154 09/24/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pivotal Therapeutics (PVTTF) 0.1154 $PVTTF

Pivotal Therapeutics Grants Incentive Stock Options
CNW Group - Mon Sep 15, 4:42PM CDT
Pivotal Therapeutics Inc. (OTCQX VTTF; CSE VO), ("Pivotal" or the "Company" , a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced today that the Board of Directors approved the granting of stock options to an officer and an advisor at the close of business on Friday, September 12, 2014. Options to acquire a total of 1,000,000 common shares of the Company were granted in accordance with the provisions of the Company's 2011 stock option plan approved by shareholders on March 10, 2011. The options are exercisable at an exercise price of $0.20 and will expire five years following the date of grant.

Pivotal Announces Publication of a Clinical Trial Showing Beneficial Effects of VASCAZEN(R) In The Correction of Omega-3 Deficiency In Cardiovascular Patients
PR Newswire Europe - Wed Sep 10, 2:30PM CDT
WOODBRIDGE, Ontario, September 10, 2014 /PRNewswire/ --

Pivotal Announces Publication of a Clinical Trial Showing Beneficial Effects of VASCAZEN® In The Correction of Omega-3 Deficiency In Cardiovascular Patients
CNW Group - Wed Sep 10, 12:49PM CDT
Pivotal Therapeutics Inc. (OTCQX VTTF; CSE VO), ("Pivotal" or the "Company" , a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease ("CVD" and overall health, announced today the publication of results of a prospective randomized controlled trial in the U.S. that evaluated the effects of VASCAZEN(®) in the correction of Omega-3 deficiency in patients with one or more risk factors associated with CVD and evaluated VASCAZEN(®)'s concomitant effects on these risk factors including triglycerides, VLDL cholesterol, LDL cholesterol, and HDL cholesterol.

Pivotal Appoints Accomplished Healthcare and Investment Industry Veteran, Prakash Gowd, as Chief Financial Officer
CNW Group - Mon Sep 08, 10:50AM CDT
Pivotal Therapeutics Inc. (OTCQX VTTF; CSE VO), ("Pivotal" or the "Company" , a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease ("CVD" and overall health, today announced the appointment of Prakash Gowd as the Company's Chief Financial Officer. Mr. Gowd succeeds Eugene Bortoluzzi, who will remain Pivotal's Chief Executive Officer.

Unique Vasoprotective and Antihypertensive Effects of VASCAZEN(R)'s Formulation Presented at ESC Congress 2014
PR Newswire Europe - Wed Sep 03, 2:01PM CDT
WOODBRIDGE, Ontario, September 3, 2014 /PRNewswire/ --

Unique Vasoprotective and Antihypertensive Effects of VASCAZEN®'s Formulation Presented at ESC Congress 2014
CNW Group - Wed Sep 03, 1:19PM CDT
Pivotal Therapeutics Inc. (OTCQX VTTF; CSE VO), ("Pivotal" or the "Company" , a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease ("CVD" and overall health, announced today that the cardio-protective effects of Pivotal's unique Omega-3 formulation commercialized as VASCAZEN(®) was presented at the 2014 Annual Scientific Meeting of the European Society of Cardiology ("ESC" Congress 2014 in Barcelona, Spain, by Rasul et al. from the Laboratory of Biophotonics and Pharmacology of the University of Strasbourg, France.

Pivotal Therapeutics Announces Second Quarter Financial Results
CNW Group - Wed Aug 27, 2:19PM CDT
Pivotal Therapeutics Inc. (OTCQX VTTF; CSE VO), ("Pivotal" or the "Company" , a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the three months ended June 30, 2014. All dollar amounts referenced herein are in Canadian dollars unless otherwise stated.

Scientific Data Supports Superiority of Pivotal's Unique Omega-3 Formulation
PR Newswire Europe - Tue Aug 19, 11:23AM CDT
WOODBRIDGE, Ontario, August 19, 2014 /PRNewswire/ --

Pivotal Therapeutics To Explore Potential Commercial Partnership Opportunities in China
CNW Group - Wed Aug 06, 11:11AM CDT
Pivotal Therapeutics Inc. (OTCQX VTTF; CSE VO), ("Pivotal" or the "Company" , a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today that it has entered into a Memorandum of Understanding to create a Joint Venture Distribution Agreement with ACGT Corporation ("ACGT" and associates. A leader in Canada's DNA services industry with extensive ties to China, ACGT will identify and introduce Pivotal to potential partners for the commercialization of its products in China.

Pivotal Therapeutics grants incentive stock options
PR Newswire - Fri Mar 14, 4:40PM CDT
Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced today that it has granted previously reserved stock options to certain of its directors, officers, employees and consultants in recognition of their contributions made in 2012. Options to acquire a total of 4,075,000 common shares of the Company were granted in accordance with the provisions of the Company's 2011 stock option plan approved by shareholders on March 10, 2011. The options are exercisable at an exercise price of $0.20 and will expire five years following the date of grant.

Pivotal Therapeutics appoints pharmaceutical executive James Connolly to Board of Directors
CNW Group - Mon Mar 10, 8:40AM CDT
Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today that James Connolly has been appointed to the Company's Board of Directors, effective immediately. Mr. Connolly brings over 27 years of experience in the pharmaceutical industry to Pivotal, including 23 years in various leadership positions at Wyeth, formerly American Home Products, a $23 billion pharmaceutical and health products company that was acquired by Pfizer in 2009.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

GomSpace's €8M Lunar Deal Pushes Mission Ambitions

Updated Category News Views 63

Moon hardware is where small-space dreams either grow teeth or chew through cash, and GomSpace has just taken another meaningful bite. The company has secured an €8 million, or 89.1 million Swedish kronor, contract for the second phase of a lunar mission program with an unnamed leading North American space company. For GOMX, this is not some vague laboratory...

Continue Reading
Zoomcar's November 23 Report Puts Execution on Trial

Updated Category News Views 89

A Date on the Board, Not a Verdict November 23 is when Zoomcar finally has to put some fresh numbers beside the story. The Bengaluru-based peer-to-peer car-sharing marketplace says it will release second-quarter fiscal 2027 financial and operating results that Monday, covering the quarter ended September 30, 2026. Management also plans a live webcast at 8:00 a.m. Eastern...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 145

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Texas Plumbing Award Signals Local Service Discipline

Updated Category News Views 51

A clogged main line is not glamorous, but it is where a local service reputation gets tested for real. Neighborhood Plumbing and Drain has been named a 2026 Best of Texas Award winner in the Plumbing Contractors category, a recognition that matters less as a trophy than as a public signal: customers around Central Texas have noticed the outfit. For anyone watching the...

Continue Reading
JDEnergy's RE+ Push Meets a Grid Hungry for Storage

Updated Category News Views 64

Certification Is Useful, Not a Victory Lap A battery box earning a safety certificate is not usually thrilling stuff, but the timing matters here. On Nov. 19, 2026, JDEnergy laid out its North American storage pitch at RE+ in Las Vegas while electricity demand is getting shoved higher by industrial buildout and AI data centers. Add more variable renewable generation to an...

Continue Reading
Refund Delays Are Becoming an E-Commerce Sales Risk

Updated Category News Views 139

A returned jacket can turn into a household cash-flow problem faster than retailers seem willing to admit. Seel's new survey lands at an awkward moment for online merchants: shoppers are not merely annoyed by slow refunds; many are budgeting around them. Among 1,921 U.S. adults who had shopped online in the prior six months, 63% said waiting for a retailer to receive a...

Continue Reading
Neusoft's OneCoreGo Win Puts Auto Software in Focus

Updated Category News Views 65

A Dashboard Award Is Not Just About Pretty Pixels Crystal-like graphics and augmented-reality pathways may sound like the sort of thing a marketing department dreams up after too much coffee, but the more interesting bit in Neusoft's latest news is the machinery underneath. OneCoreGo 7.0 has received the Red Dot Design Award after taking a German iF Design Award earlier...

Continue Reading
Bella Rio's Proposed Preferred B Share Giveaway Plan

Updated Category News Views 24

A founder handing over two million of his own common shares is the sort of detail that makes investors stop stirring their coffee. Bella Rio Consulting, the company behind ROCK'N Vodka and Bella Rio Bourbon, says co-founder and Vice President Andy Roiniotis proposes to contribute 2,000,000 personally held Common shares for reclassification into Preferred Series B shares....

Continue Reading
2027 Auto Brand Awards Put Long-Term Buyer Value First Again

Updated Category News Views 81

Car shoppers staring down high prices and financing costs do not need another shiny badge; they need some help separating durable value from showroom wallpaper. That is why the 2027 U.S. News vehicle brand awards, announced Nov. 19, 2026, are worth a look. They are not a sales forecast, not a profit forecast, and certainly not a reason to blindly crown a corporate winner....

Continue Reading
Trip.com Sets December 1 Date for Third-Quarter Results

Updated Category News Views 108

December’s first after-hours session will put Trip.com Group back under the market’s microscope, whether anybody is ready or not. The company says it will report results for the three months ended September 30, 2026 after the U.S. market closes on Tuesday, December 1. That is the whole hard-news payload for now: a reporting date, a call time, and no numbers to get...

Continue Reading

Top 5 Most Recently Viewed Articles

Greenwave Technology's Bold $4 Million Rare Earth Metals Strategy

Updated Category News Views 181

Greenwave Technology Solutions Takes Bold Steps Greenwave Technology Solutions, Inc. (NASDAQ: GWAV) recently announced a significant initiative to enhance its capabilities in rare earth metals recovery. This strategy entails raising $4 million through a securities purchase agreement with institutional and accredited investors. With a current market capitalization of...

Continue Reading
Exploring NewAmsterdam Pharma's Breakthrough Alzheimer’s Findings

Updated Category News Views 164

NewAmsterdam Pharma Unveils Exciting Alzheimer’s Data NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) has made strides in the study of Alzheimer’s disease. During a recent conference, the company presented compelling data from its BROADWAY trial, focusing on significant reductions in key Alzheimer’s biomarkers. This innovative research highlights obicetrapib's...

Continue Reading
Persistent Systems Reports Impressive Q3 Growth and Innovation

Updated Category News Views 202

Persistent Systems Achieves Strong Financial Performance Declares interim dividend of ?20 per share Persistent Systems (BSE: 533179) (NSE: PERSISTENT) has announced impressive financial results for the quarter ending December 31, showcasing a total revenue of $360.2 million. This success marks a 4.3% increase quarter-over-quarter and an outstanding 19.9% year-over-year...

Continue Reading
Nasdaq Announces Market Closure in Tribute to President Carter

Updated Category News Views 122

Nasdaq to Honor President Carter with Market Closure In a significant gesture of respect, Nasdaq (NASDAQ:NDAQ), a prominent market operator, will close all U.S. equities and options markets on January 9, 2025. This closure comes in memory of the former President Jimmy Carter, honoring his profound impact on American society. The announcement coincides with the nation’s...

Continue Reading
How a $100 Investment in Tenet Healthcare Could Grow Today

Updated Category News Views 187

The Remarkable Journey of Tenet Healthcare Tenet Healthcare (NYSE: THC) has shown impressive growth and resilience over the past 15 years. On average, the company has outstripped market returns by 5.36% annually, delivering an average annual return of 17.55%. With a current market capitalization of $17.35 billion, Tenet has proven to be a strong player in the healthcare...

Continue Reading